Posts by: Alice Melão

News

Researchers at Israel’s Ben-Gurion University (BGU) have developed an artificial intelligence (AI) platform that can help monitor and predict the course of amyotrophic lateral sclerosis (ALS). The tool was designed ... Read more

February 19, 2019February 19, 2019

Vps4 Protein Found to Protect Nerve Cells from Degeneration, Study Shows

News

Enhanced production of a protein called Vps4 was shown to delay the degenerative process in injured nerve cells, which may help researchers to better understand and treat nerve damage ... Read more

February 12, 2019February 12, 2019

Recumbent Stepper Safe, Feasible Exercise for ALS Patients, Study Suggests

News

Using a recumbent stepper is a safe and well-tolerated way for patients with amyotrophic lateral sclerosis (ALS) to do physical exercise, a pilot study suggests. The study, “Recumbent stepping ... Read more

January 30, 2019January 30, 2019

Researchers Move Closer to Giving Voice to Those Who Cannot Speak

News

A “new voice” for people who cannot verbally communicate, such as those living with amyotrophic lateral sclerosis (ALS) or recovering from stroke, is a step closer to becoming reality. ... Read more

January 21, 2019January 21, 2019

Nearly 60% of ALS Patients are Excluded from Clinical Trials, Stressing the Need for New Eligibility Criteria, Study Shows

News

The majority of patients with amyotrophic lateral sclerosis (ALS) are excluded from participating in clinical trials, a large study has revealed. This finding raises questions on the extrapolation of ... Read more

January 8, 2019January 8, 2019

Healthcare AI Company and Neurological Center Collaborating on New Tool to Improve ALS Management

News

CloudMedx plans to develop a computer analysis algorithm that will track the clinical progression of patients with amyotrophic lateral sclerosis (ALS) to predict treatment outcomes. This tool will be ... Read more

January 3, 2019January 3, 2019

Impaired Emotion Recognition is Sign of Behavioral Symptoms in ALS, Study Finds

News

Difficulty in recognizing emotions may be a sign of changes in the frontal lobe of the brain and associated behavioral symptoms in patients with amyotrophic lateral sclerosis (ALS). The ... Read more

January 2, 2019January 2, 2019

Analyses of Cytokinetics’ Clinical Data Provide Insights on ALS Care, Trial Design

News

Exploratory analysis of data collected in the FORTITUDE-ALS and VITALITY-ALS trials sponsored by Cytokinetics provide new insights to enhance the design of future clinical trials in amyotrophic lateral sclerosis ... Read more

December 17, 2018December 17, 2018

Patients Seek Therapies That Might Stop Progression and Ease Burden of ALS, Online Survey Finds

News

The majority of patients with amyotrophic lateral sclerosis (ALS) report wanting new treatments to stop their disease’s progression and so improve breathing function, muscle strength, and mobility, according to the results ... Read more

Posts by: Alice Melão

Alice Melão

Researchers Develop Predictive Platform for Personalized Care of ALS Patients

Vps4 Protein Found to Protect Nerve Cells from Degeneration, Study Shows

Recumbent Stepper Safe, Feasible Exercise for ALS Patients, Study Suggests

Researchers Move Closer to Giving Voice to Those Who Cannot Speak

Nearly 60% of ALS Patients are Excluded from Clinical Trials, Stressing the Need for New Eligibility Criteria, Study Shows

Healthcare AI Company and Neurological Center Collaborating on New Tool to Improve ALS Management

Impaired Emotion Recognition is Sign of Behavioral Symptoms in ALS, Study Finds

Top 10 ALS Stories of 2018

Analyses of Cytokinetics’ Clinical Data Provide Insights on ALS Care, Trial Design

Patients Seek Therapies That Might Stop Progression and Ease Burden of ALS, Online Survey Finds

Pin It on Pinterest